Chief, Molecular Neuropsychiatry, National Institute of Health (NIH), NIDA
Dr. Cadet is recognized as one of the national leaders in addiction research. He graduated from Columbia University, College of Physicians and Surgeons, in 1979. After finishing his independent residencies in Psychiatry (Columbia University) and Neurology (Mt. Sinai) he did a fellowship in neuropsychiatry at the National Institute of Mental Health. He was an Assistant Professor of Neurology and Psychiatry at Columbia University before joining the National Institute on Drug Abuse (NIDA) in 1992.
He joined the NIMH-IRP as a neuropsychiatry fellow from 1984-1987. He is the author of numerous high impact papers on drug effects on the brain. His publications focus most extensively on the cellular and molecular mechanisms of METH-induced neurodegeneration and on the cognitive effects of marijuana and cocaine. These papers appeared in journals such as Annals of Neurology, Biological Psychiatry, FASEB Journal, JBC, Journal of Neuroscience, Neurology and PNAS.
He is presently Chief of the Molecular Neuropsychiatry Section and of the Molecular Neuropsychiatry Research Branch at the NIH/NIDA Intramural Research Program. His research interests include (1) clinical neurobiology of drug abuse and addiction, (2) cellular and molecular neurotoxicity of drug abuse, (3) the involvement of free radicals in neurodegeneration, (4) the role of cell death-related genes in the toxicity of drug abuse, (5) the participation of catecholamines in neurodegenerative disorders and (6) the role of epigenetic mechanisms in drug addiction. He is a reviewer for many basic and clinical journals. Recently Dr. Cadet was the recipient of the Harvey Bullock, Jr. Award for Diversity in Science.
As the Associate Director for Diversity and Outreach, Dr. Cadet’s greatest passion is the recruitment of young scientists from under-represented populations into various NIH programs. He has been in charge of recruiting summer students into the NIDA-IRP since 1995.